Pacific Biosciences of California Logo

Pacific Biosciences of California

🇺🇸
PACB
US69404D1081

Pacific Biosciences of California is a leading biotechnology company in DNA sequencing technology. It develops and markets innovative HiFi sequencing systems that provide comprehensive genomic data for biomedical research. The company empowers scientists to solve complex genetic questions, advancing genomics, diagnostics, and precision medicine.

Next Quarterly Earnings

Wednesday, November 11, 2026
CW 46
After-Hours
In 76 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 14, 2026

Stock Price

Frequently asked questions

When will Pacific Biosciences of California report its next quarterly earnings?

Pacific Biosciences of California is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Pacific Biosciences of California last report quarterly earnings?

Pacific Biosciences of California last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.14 USD.

How does Pacific Biosciences of California stock react to earnings?

Across its last 3 earnings reports, Pacific Biosciences of California stock moved by ±9.6% on average the following day. The largest reaction was -14.6% on 05/07/2026; 0 of 3 reactions were positive.

How often has Pacific Biosciences of California beaten expectations?

Pacific Biosciences of California has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Pacific Biosciences of California earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.13
Actual:
Q2 2026
Met
Estimate:-$0.14
Actual:-$0.14
Difference:+$0.00
Q1 2026
Beat
Estimate:-$0.14
Actual:-$0.03
Difference:+$0.11
Price reaction (1 day):-14.6 %
Price reaction (7 days):-26.7 %
Q4 2025
Beat
Estimate:-$0.14
Actual:-$0.13
Difference:+$0.01
Price reaction (1 day):-7.1 %
Price reaction (7 days):-8.7 %
Q3 2025
Beat
Estimate:-$0.14
Actual:-$0.12
Difference:+$0.02
Price reaction (1 day):-7.3 %
Price reaction (7 days):-9.4 %
Q1 2025
Beat
Estimate:-$0.17
Actual:-$0.13
Difference:+$0.04

Earnings statistics

Stock reaction to earnings

±9.6%
Avg. next-day move
-14.6%
Largest move (05/07/2026)
0%
Share of positive reactions
±14.9%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
+17.6%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Pacific Biosciences of California
Ticker Symbol
PACB
ISIN
US69404D1081
Country
🇺🇸
USA
Sector